Saturday Rounds: Week of July 26-31, 2026

Biotech’s week was a proof filter, not a rally: XBI fell while J&J committed billions to unvalidated delivery and in vivo cell-programming platforms, and FDA advisory votes split sharply on Replimune and Capricor. Weekly Biotech Signal Review · Week of July 26–31, 2026 · Published…